Due to the decrease of SLC4A4 mRNA expression in multiple malignancies (Fig. 2A), including breast cancer, lung cancer, gastric cancer, and ovarian cancer, we further assessed the correlation between SLC4A4 mRNA expression and survival of patients, including OS, RFS, PPS, DMPS, FP or PFS. This evidence concerns the gene SLC4A4 and breast carcinoma.